Back
Janux Therapeutics 10K Form
Sell
34
JANX
Janux Therapeutics
Last Price:
50.47
Seasonality Move:
7.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive JANX News And Ratings
See the #1 stock for the next 7 days that we like better than JANX
JANX Financial Statistics
Sales & Book Value
| Annual Sales: | $8.08M |
|---|---|
| Cash Flow: | $-2.26M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $12.54 |
| Price / Book: | 3.72 |
Profitability
| EPS (TTM): | -1.16000 |
|---|---|
| Net Income (TTM): | $-60.54M |
| Gross Margin: | -- |
| Return on Equity: | -11.37% |
| Return on Assets: | -10.65% |
Janux Therapeutics Earnings Forecast
Key Janux Therapeutics Financial Ratios
- The Research & Development expenses have been 679.48% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of JANX is -721.18% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 2 years.
Janux Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | JANX |
| Website: | januxrx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 38.8 |
| Quick Ratio: | 38.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
JANX Technical Analysis vs Fundamental Analysis
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a Sell
The current Janux Therapeutics [JANX] share price is $46.50. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.